How GlaxoSmithKline Lost Nearly $10B in October Post author:Sam Post published:November 9, 2017 Post category:BioPharma Could GlaxoSmithKline’s industry-leading dividend be at risk? Source: BioSpace You Might Also Like Mysterious Moderna Hints at Its IPO Timeline November 2, 2017 26 Patients Dead After Replacing Controller for Abbott's HeartMate II Blood Pumps at Home May 23, 2017 Gilead Announces Second Quarter 2017 Financial Results July 26, 2017
26 Patients Dead After Replacing Controller for Abbott's HeartMate II Blood Pumps at Home May 23, 2017
